Koios Care is thrilled to announce that we have successfully raised $1,000,000 in our latest funding round—a significant milestone that will further empower our mission of revolutionizing neurological care. At Koios Care, our pioneering platform leverages commercially available devices to deliver precise, actionable neuroscience data. This breakthrough technology enables patients to take control of their own health, supports clinicians in optimizing treatment strategies, and provides robust, data-driven insights to fuel pharmaceutical research and development. With this new injection of capital, we are poised to enhance our technological offerings, expand our network of clinical and research partners, and ultimately drive better outcomes for individuals living with neurological conditions.
This funding will be dedicated to refining our data analytics capabilities and bolstering the integration of our services within clinical settings. Our vision is to expand access to advanced neurological diagnostics and tailored treatment options, paving the way for groundbreaking advancements in both patient care and pharmaceutical innovation. As we continue to impact hundreds of lives, our commitment to empowering patients and clinicians alike remains unwavering. The investment also serves as a testament to the confidence that leading figures in the pharma industry have in our approach and our technologies.
This achievement marks an exciting step forward in our journey to modernize healthcare. As we move ahead, Koios Care is more dedicated than ever to enhancing our platform, forging new collaborations, and setting a higher standard for neurological health management. We are grateful for the support of our investors and partners, and we look forward to continuing to share our progress as we deliver on our promise of transforming the landscape of neurological care.
